Necrosis and Apoptosis: Distinct Cell Loss Mechanisms in a Mathematical Model of Avascular Tumour Growth

During the initial avascular phase of solid tumour growth. it is the balance between cell proliferation and cell loss that determines whether the tumour colony expands or regresses. Experimentalists have identified two distinct mechanisms that contribute to cell loss. These are apoptosis and necrosis. Cell loss due to apoptosis may be referred to as programmed-cell-death, occurring. for example, when a cell exceeds its natural lifespan. In contrast, cell loss due to necrosis is induced by changes in the cell's microenvironment. occurring, for example, in nutrient-depleted regions of the tumour. In this paper we present a mathematical model that describes the growth of an avascular tumour which comprises a central core of necrotic cells, surrounded by an outer annulus of proliferating cells. The model distinguishes between apoptosis and necrosis. Using a combination of numerical and analytical techniques we present results which suggest how the relative importance of apoptosis and necrosis changes as the tumour develops. The implications of these results are discussed briefly.

[1]  M. A. J. Chaplain,et al.  The mathematical modelling of tumour angiogenesis and invasion , 1995, Acta biotheoretica.

[2]  K. Groebe,et al.  Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters , 2004, European Biophysics Journal.

[3]  Guy Makin,et al.  Apoptosis and cancer chemotherapy , 2000, Cell and Tissue Research.

[4]  K Groebe,et al.  On the relation between size of necrosis and diameter of tumor spheroids. , 1996, International journal of radiation oncology, biology, physics.

[5]  H M Byrne,et al.  Mathematical models for tumour angiogenesis: numerical simulations and nonlinear wave solutions. , 1995, Bulletin of mathematical biology.

[6]  Helen M. Byrne,et al.  The role of growth factors in avascular tumour growth , 1997 .

[7]  H M Byrne,et al.  Growth of nonnecrotic tumors in the presence and absence of inhibitors. , 1995, Mathematical biosciences.

[8]  R. Durand Invited review Multicell spheroids as a model for cell kinetic studies , 1990, Cell and tissue kinetics.

[9]  N. Kyprianou,et al.  Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF‐β1 and bcl‐2 expression , 1996, International journal of cancer.

[10]  R. Auerbach,et al.  Tumor-induced neovascularization in the mouse eye. , 1982, Journal of the National Cancer Institute.

[11]  H M Byrne,et al.  The effect of time delays on the dynamics of avascular tumor growth. , 1997, Mathematical biosciences.

[12]  J. Leith,et al.  Changes in the extents of viable and necrotic tissue, interstitial fluid pressure, and proliferation kinetics in clone A human colon tumour xenografts as a function of tumour size , 1994 .

[13]  D. McElwain,et al.  Apoptosis as a volume loss mechanism in mathematical models of solid tumor growth , 1978 .

[14]  J. Folkman The vascularization of tumors. , 1976, Scientific American.

[15]  C. Potten The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice , 1992, Cancer and Metastasis Reviews.

[16]  J. King,et al.  Mathematical modelling of avascular-tumour growth. , 1997, IMA journal of mathematics applied in medicine and biology.

[17]  C. Potten,et al.  Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. , 1996, British Journal of Cancer.

[18]  P. Groscurth,et al.  Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA , 1994, Cell and Tissue Research.

[19]  H. Greenspan On the growth and stability of cell cultures and solid tumors. , 1976, Journal of theoretical biology.

[20]  H M Byrne,et al.  Growth of necrotic tumors in the presence and absence of inhibitors. , 1996, Mathematical biosciences.

[21]  J. Adam A simplified mathematical model of tumor growth , 1986 .

[22]  R. Sutherland,et al.  Growth and cellular characteristics of multicell spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  P K Maini,et al.  Nonlinear diffusion of a growth inhibitory factor in multicell spheroids. , 1994, Mathematical biosciences.

[24]  J P Freyer,et al.  In situ oxygen consumption rates of cells in V‐79 multicellular spheroids during growth , 1984, Journal of cellular physiology.

[25]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[26]  Y. Soini,et al.  Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity , 1997, The Journal of pathology.

[27]  N F Britton,et al.  On the concentration profile of a growth inhibitory factor in multicell spheroids. , 1993, Mathematical biosciences.

[28]  D. Fisher,et al.  Mechanisms of apoptotic cell death , 1997, Leukemia.

[29]  A. Ruifrok,et al.  Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism. , 1996, International journal of radiation oncology, biology, physics.

[30]  J. A. Adam,et al.  Diffusion regulated growth characteristics of a spherical prevascular carcinoma , 1990 .

[31]  Christine E. Canman,et al.  P53, cell cycle control and apoptosis: Implications for cancer , 1995, Cancer and Metastasis Reviews.

[32]  M. Chaplain,et al.  Modelling the role of cell-cell adhesion in the growth and development of carcinomas , 1996 .

[33]  J F Kerr,et al.  Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.

[34]  W. Mueller‐Klieser,et al.  Multicellular spheroids , 2004, Journal of Cancer Research and Clinical Oncology.

[35]  M. Borner,et al.  Apoptosis: Its Role in the Development of Malignancies and its Potential as a Novel Therapeutic Target , 1997, The Annals of pharmacotherapy.

[36]  I. Lauder,et al.  Correlation between apoptosis, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma , 1996, Clinical molecular pathology.

[37]  D. Bredesen,et al.  Expression of bcl‐2 inhibits necrotic neural cell death , 1995, Journal of neuroscience research.

[38]  M. Chaplain,et al.  A model mechanism for the chemotactic response of endothelial cells to tumour angiogenesis factor. , 1993, IMA journal of mathematics applied in medicine and biology.

[39]  Mark A. J. Chaplain,et al.  A mathematical model of vascular tumour growth and invasion , 1996 .

[40]  R. Ward,et al.  Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia. , 1997, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[41]  H. Greenspan Models for the Growth of a Solid Tumor by Diffusion , 1972 .

[42]  M. Jäättelä,et al.  [Mechanisms of apoptotic cell death]. , 1997, Duodecim; laaketieteellinen aikakauskirja.

[43]  Z. Darżynkiewicz Apoptosis in anititumor strategies: Modulation of cell cycle or differentiation , 1995, Journal of cellular biochemistry.

[44]  M. Tubiana The kinetics of tumour cell proliferation and radiotherapy. , 1971, The British journal of radiology.

[45]  D. Balding,et al.  A mathematical model of tumour-induced capillary growth. , 1985, Journal of theoretical biology.